Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Diabetes

Low HbA1c levels and mortality in type 2 diabetes mellitus

Nature Reviews Endocrinology volume 6, pages 359–360 (2010)Cite this article

Subjects

A novel study published in The Lancet suggests a U-shaped association between HbA1c levels and mortality in patients with type 2 diabetes mellitus. But is a revision of current guidelines to include a minimum HbA1c target advisable on the basis of these findings?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Action to Control Cardiovascular Risk in Diabetes Study Group et al. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545–2559 (2008).

  2. Currie, C. J. et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 375, 481–489 (2010).

    Article  CAS  PubMed  Google Scholar 

  3. Wannamethee, G., Shaper, A. G., Whincup, P. H. & Walker, M. Low serum total cholesterol concentrations and mortality in middle aged British men. BMJ 311, 409–413 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kosiborod, M. et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 301, 1556–1564 (2009).

    Article  CAS  PubMed  Google Scholar 

  5. Riddle, M. C. A1C and mortality risk in ACCORD. Presented at the American Diabetes Association 69th Scientific Sessions (2009).

  6. Engel-Nitz, N. M., Martin, S., Sun, P., Buesching, D. & Fonseca, V. Cardiovascular events and insulin therapy: a retrospective cohort analysis. Diabetes Res. Clin. Pract. 81, 97–104 (2008).

    Article  CAS  PubMed  Google Scholar 

  7. Kelly, T. N. et al. Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann. Intern. Med. 151, 394–403 (2009).

    Article  PubMed  Google Scholar 

  8. Khaw, K. T. et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322, 15–18 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Selvin, E. et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N. Engl. J. Med. 362, 800–811 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Skyler, J. S. et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. J. Am. Coll. Cardiol. 53, 298–304 (2009).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Tulane University Health Sciences Center, 1430 Tulane Avenue, New Orleans, 70112, LA, USA

    Shamsa Ali & Vivian A. Fonseca

Authors
  1. Shamsa Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivian A. Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vivian A. Fonseca.

Ethics declarations

Competing interests

S. Ali declares no competing interests. V. A. Fonseca declares an association with the following companies: AstraZeneca (research support), Daiichi Sankyo (research support/honoraria for consulting and lectures), Eli Lilly (research support/honoraria for consulting and lectures), GlaxoSmithKline (research support/honoraria for consulting and lectures), Novartis (research support/honoraria for consulting and lectures), Novo Nordisk (research support/honoraria for consulting and lectures), Sanofi-Aventis (research support/honoraria for consulting and lectures), Takeda (research support/honoraria for consulting and lectures).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ali, S., Fonseca, V. Low HbA1c levels and mortality in type 2 diabetes mellitus. Nat Rev Endocrinol 6, 359–360 (2010). https://doi.org/10.1038/nrendo.2010.69

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2010.69

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing